2025 EVENT SITE
WMIF MAIN SITEMonday, September 15, 2025
03:05 PM - 03:45 PM
Discovery of effective antibiotics has been one of the hallmark achievements of modern medicine. Maladies that historically decimated populations have been mitigated if not eliminated through developments in diagnosing and treating infectious diseases. Partly due to the overuse of one of the mainstays of medical treatment, antibiotics, resistance to treatment is emerging and no immediate replacement appears to be available. This session will discuss the growing threat of antibiotic resistance and what scientific, clinical and policy approaches may help mitigate that threat.
Moderator
Michael Gilmore, PhD,
Chief Scientific Officer, Mass Eye and Ear;
Sir William Osler Professor of Ophthalmology, Harvard Medical School
Speakers
Kevin Krause,
President & CEO, ArrePath
Robin Patel, MD,
Director, Infectious Diseases Research Laboratory, Mayo Clinic
Erica Shenoy, MD, PhD,
Chief of Infection Control, Mass General Brigham;
Associate Professor of Medicine, Harvard Medical School